AbbVie Inc. Total Debt 2012–2025
AbbVie Inc. reported $67.00B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.2% higher than fiscal 2024. Compared with fiscal 2020, the change was -21.2%.
| Fiscal year | Total Debt | Change (YoY) |
|---|---|---|
| FY 2025 | $67.00B | +0.2% |
| FY 2024 | $66.84B | +12.8% |
| FY 2023 | $59.24B | -6.2% |
| FY 2022 | $63.13B | -16.9% |
| FY 2021 | $75.98B | -10.6% |
| FY 2020 | $84.98B | +26.4% |
| FY 2019 | $67.23B | +1717.6% |
| FY 2018 | $3.70B | +824.8% |
| FY 2017 | $400.00M | +6.1% |
| FY 2016 | $377.00M | -7.1% |
| FY 2015 | $406.00M | -4.5% |
| FY 2014 | $425.00M | +2.9% |
| FY 2013 | $413.00M | -59.5% |
| FY 2012 | $1.02B | — |
Source: AbbVie Inc. SEC filings — balance sheet (10-K). Computed deterministically; refreshed nightly (last updated August 2, 2026). Open ABBV 10-K filings at SEC EDGAR · Methodology · Download CSV.
How to read this history
AbbVie Inc. reported $67.00B of total debt (short- plus long-term borrowings) for fiscal 2025. That was 0.2% higher than fiscal 2024. Compared with fiscal 2020, the change was -21.2%. Values remain missing when the cached filing does not disclose a comparable line item; they are never estimated. Stock splits, reorganizations and fiscal-calendar changes can reduce comparability.
Prepared and reviewed by the stockportfolio.pro research desk. Corrections: support@stockportfolio.pro.
See the full picture for AbbVie Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeAbbVie Inc. — frequently asked questions
What is AbbVie Inc.'s total debt (short- plus long-term borrowings)?
AbbVie Inc. (ABBV) reported total debt (short- plus long-term borrowings) of $67.00B for fiscal year 2025, per its SEC filings.
How has AbbVie Inc.'s total debt (short- plus long-term borrowings) changed over time?
Between fiscal 2012 and 2025, ABBV's total debt (short- plus long-term borrowings) grew at roughly 38.0% per year (compound annual rate), from $1.02B to $67.00B.
Where does this data come from?
Figures are computed from AbbVie Inc.'s official SEC filings (balance sheet (10-K)), refreshed nightly. Not investment advice.
More ABBV financial history
Full ABBV fundamentals page → · Analyze total debt (short- plus long-term borrowings) with a free tool → · All 1,500+ companies →